Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Revenue: 2012-2024

Historic Revenue for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $732.0 million.

  • Amphastar Pharmaceuticals' Revenue rose 0.33% to $191.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $723.3 million, marking a year-over-year decrease of 0.03%. This contributed to the annual value of $732.0 million for FY2024, which is 13.59% up from last year.
  • Amphastar Pharmaceuticals' Revenue amounted to $732.0 million in FY2024, which was up 13.59% from $644.4 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Revenue high stood at $732.0 million for FY2024, and its period low was $349.8 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $644.4 million (2023), whereas its average is $625.1 million.
  • Data for Amphastar Pharmaceuticals' Revenue shows a peak YoY grew of 29.14% (in 2023) over the last 5 years.
  • Over the past 5 years, Amphastar Pharmaceuticals' Revenue (Yearly) stood at $349.8 million in 2020, then rose by 25.13% to $437.8 million in 2021, then rose by 13.98% to $499.0 million in 2022, then climbed by 29.14% to $644.4 million in 2023, then increased by 13.59% to $732.0 million in 2024.